SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-053165
Filing Date
2017-09-18
Accepted
2017-09-18 16:40:55
Documents
1
Period of Report
2017-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7172
  Complete submission text file 0001209191-17-053165.txt   8643
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONCERT PHARMACEUTICALS INC. 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address
Lynch Ryan (Reporting) CIK: 0001709271 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36310 | Film No.: 171090233